Tempus AI's shift toward scalable revenues, high-margin data services and broader AI capabilities defines a pivotal moment for TEM investors.

There are at least 500 sudden and unexpected deaths in the city each year, and in roughly a fifth of those cases, a genetic ...

Accelerated sequencing technologies, AI-enabled analytics, newborn screening expansion, and government-backed genomic initiatives fuel rapid growth across North America, Europe, and ...

Tempus AI, Inc. remains a Buy with operational performance and partnerships strengthening the long-term thesis. Learn more ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to ...

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

Genetic ancestry is a concept that has long captured people’s imaginations. It’s no surprise that it’s been turned into a ...

A sprawling illegal trade in prenatal testing has triggered alarm – less about illegal sex selection than about who might end ...

Genetic factors account for much of the variation in personality traits across the lifespan. Shared upbringing plays a ...

If a jeans advert hinting at actress Sydney Sweeney's "good genes" sent the internet into a frenzy over eugenics - how about one for a company that's actually selling good genes? Posters have appeared ...

A "simple" genetic test for newborns that will help to prevent deafness caused by a common antibiotic is to be rolled out across Scotland. Doctors often prescribe Gentamicin to babies showing signs of ...